Department of Clinical Oncology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
Clinical Hematology and Bone Marrow Transplant Unit, Civil Service Hospital, Minbhawan, Kathmandu, Nepal.
JNMA J Nepal Med Assoc. 2020 Aug 31;58(228):560-563. doi: 10.31729/jnma.5194.
Distress is a major concern during diagnosis and treatment of hematological malignancies. The Distress Thermometer is a commonly used screening tool to detect distress. The objectives of this study was to know the prevalence and identify distress score among patients with hematological malignancies in Nepal.
A descriptive cross sectional study was carried out at the Hematology Unit of Civil Service Hospital after obtaining an ethical approval from the Institutional Review Committee (reference number 931/076/077). A convenient sampling technique was used for this study. Statistical Package for the Social Sciences version 20.0 was used. All patients within one week of diagnosis and before the start of definitive treatment of hematological malignancies were included in the study. National Comprehensive Cancer Network Psychosocial Distress Screening Tool was used to measure the seriousness of distress.
A total of 100 patients were enrolled in the study, among them 56 (56%) were male and 44 (44%) were female. The mean distress score in our study was found to be 5.68±1.75. Mean distress score among male and female patients were 5.84±1.65 and 5.48±1.86 respectively. Thirty three percentage (n=33) of patient had mild distress whereas, sixty six percentage (n=67) of patients experienced moderate to severe distress.
There was a significant level of distress among the patients with hematological malignancies in Nepal. Therefore, distress screening should be done to all the patients when initial diagnosis is made.
在血液病的诊断和治疗过程中,痛苦是一个主要问题。痛苦温度计是一种常用的筛查工具,用于检测痛苦。本研究的目的是了解尼泊尔血液病患者的痛苦发生率并确定痛苦评分。
本研究是在获得机构审查委员会(参考号 931/076/077)的伦理批准后,在公务员医院血液科进行的描述性横断面研究。本研究采用便利抽样技术。使用社会科学统计软件包 20.0 进行统计分析。所有在确诊后一周内且在开始血液病确定性治疗之前的患者均纳入本研究。使用国家综合癌症网络心理困扰筛查工具来衡量痛苦的严重程度。
本研究共纳入 100 例患者,其中 56 例(56%)为男性,44 例(44%)为女性。我们的研究发现,平均痛苦评分是 5.68±1.75。男性和女性患者的平均痛苦评分分别为 5.84±1.65 和 5.48±1.86。33%(n=33)的患者有轻度痛苦,而 66%(n=67)的患者有中度至重度痛苦。
尼泊尔血液病患者存在明显的痛苦水平。因此,在初始诊断时应对所有患者进行痛苦筛查。